PFE: Reports Phase 3 Results
Pfizer announces topline Phase 3 results for Sigvotatug Vedotin in previously treated metastatic non-squamous non-small cell lung cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.